Astera Labs (NASDAQ:ALAB) Issues Q2 2026 Earnings Guidance

Astera Labs (NASDAQ:ALAB) issued an update on its second quarter 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.680-0.700 for the period, compared to the consensus EPS estimate of 0.500. The company issued revenue guidance of $355.0 million-$365.0 million, compared to the consensus revenue estimate of $310.0 million.

Analyst Ratings Changes

Several research firms have commented on ALAB. UBS Group started coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective for the company. Morgan Stanley lifted their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday. Needham & Company LLC lifted their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday. Royal Bank Of Canada lifted their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday. Finally, Loop Capital initiated coverage on shares of Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective for the company. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $219.65.

Astera Labs Trading Down 4.1%

Shares of ALAB traded down $8.90 during mid-day trading on Wednesday, hitting $206.79. The company’s stock had a trading volume of 5,181,724 shares, compared to its average volume of 5,342,628. The company’s 50-day moving average is $140.72 and its 200-day moving average is $153.38. Astera Labs has a 52-week low of $63.40 and a 52-week high of $262.90. The firm has a market capitalization of $35.42 billion, a price-to-earnings ratio of 169.52, a PEG ratio of 3.96 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the prior year, the company earned $0.33 EPS. The company’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts predict that Astera Labs will post 1.48 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 3,757 shares of the company’s stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $175.12, for a total value of $657,925.84. Following the completion of the sale, the director owned 67,144 shares of the company’s stock, valued at approximately $11,758,257.28. This represents a 5.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the sale, the general counsel directly owned 118,084 shares of the company’s stock, valued at $12,725,912.68. The trade was a 7.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,064,888 shares of company stock worth $150,764,723 over the last quarter. 12.50% of the stock is currently owned by company insiders.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 results and upgraded Q2 guidance: Astera reported a sizable beat (Q1 EPS $0.61 vs. $0.54 consensus; revenue $308.4M vs. ~$292M) and issued Q2 EPS guidance of $0.68–$0.70 vs. consensus ~ $0.50 — the beats and raise are the primary catalyst behind recent upside. Astera Labs Reports First Quarter 2026 Financial Results
• Positive Sentiment: New product momentum: The company is shipping its 320-lane Scorpio X?Series smart fabric switch to hyperscalers, strengthening its position in AI scale?up networking and supporting revenue/market-share growth expectations. Scorpio X?Series Shipping Announcement
• Positive Sentiment: Analyst upgrades to higher price targets (Stifel and Needham to $260, buy): multiple firms raised targets after the report, signaling increased street conviction on growth and giving the stock additional near?term buying support. Benzinga Coverage of Analyst Raises
• Positive Sentiment: Broad bullish coverage and momentum: sell?side and independent writeups (Seeking Alpha, TipRanks, MarketWatch) and public mentions (e.g., Jim Cramer) have amplified demand and investor interest after the beat-and-raise. Seeking Alpha: Superb Q1
• Neutral Sentiment: Susquehanna raised its price target to $230 but kept a “neutral” rating — positive to the target but less bullish on conviction than other shops. Susquehanna Coverage
• Neutral Sentiment: Earnings call and transcript available — useful for drilling into management’s commentary on product mix, gross margins (Q1 gross margin expansion noted), inventory and hyperscaler demand but not an immediate price catalyst by itself. Earnings Call Transcript
• Neutral Sentiment: Consensus analyst stance: the stock has an average rating around “moderate buy” — supportive but mixed across firms. Analyst Consensus
• Negative Sentiment: Valuation concerns and profit?taking: coverage questioning whether ALAB is overvalued after the run-up has likely prompted some selling; ALAB’s high P/E and rapid share appreciation increase sensitivity to short?term pullbacks. Yahoo: Is ALAB Overvalued?

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Smartleaf Asset Management LLC grew its position in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in shares of Astera Labs in the 4th quarter worth approximately $33,000. Wexford Capital LP purchased a new position in shares of Astera Labs in the 3rd quarter worth approximately $39,000. National Bank of Canada FI grew its position in shares of Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after buying an additional 124 shares during the last quarter. Finally, Silicon Valley Capital Partners purchased a new position in shares of Astera Labs in the 4th quarter worth approximately $50,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.